Skip to main content

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Clinical Pathways and Policy to Guard Against Misaligned Incentives
Clinical Pathways GPS
02/18/2020
The application of clinical pathways and their enforcement through quality metric benchmark setting and appropriate use criteria is needed to guard against perverse financial incentives that encourage overutilization...
The application of clinical pathways and their enforcement through quality metric benchmark setting and appropriate use criteria is needed to guard against perverse financial incentives that encourage overutilization...
The...
02/18/2020
Journal of Clinical Pathways
Clinical Pathways GPS
11/18/2019
As total cost of care increasingly becomes a major issue in the United States, both market solutions like clinical pathways and government solutions such as drug pricing regulations are being proposed. Each solution...
As total cost of care increasingly becomes a major issue in the United States, both market solutions like clinical pathways and government solutions such as drug pricing regulations are being proposed. Each solution...
As...
11/18/2019
Journal of Clinical Pathways
Clinical Pathways GPS
08/19/2019
As the Medicare for All (M4A) debate continues into 2020, clinical pathway organizations, payers, health systems, providers, and patients will all play a role in shaping future policies around patient access and...
As the Medicare for All (M4A) debate continues into 2020, clinical pathway organizations, payers, health systems, providers, and patients will all play a role in shaping future policies around patient access and...
As the...
08/19/2019
Journal of Clinical Pathways
Clinical Pathways GPS
05/15/2019
Chimeric antigen receptor (CAR) T-cell therapy is a new form of cancer therapy that uses a patient’s own immune system to fight the disease. This type of cell therapy uses an individualized process to develop a...
Chimeric antigen receptor (CAR) T-cell therapy is a new form of cancer therapy that uses a patient’s own immune system to fight the disease. This type of cell therapy uses an individualized process to develop a...
...
05/15/2019
Journal of Clinical Pathways
Clinical Pathways GPS
03/13/2019
The Center of Excellence (CoE) model of care is an excellent approach to the growing need for disease-based medical management of chronic-type conditions with its multidisciplinary team approach and dedication to...
The Center of Excellence (CoE) model of care is an excellent approach to the growing need for disease-based medical management of chronic-type conditions with its multidisciplinary team approach and dedication to...
The...
03/13/2019
Journal of Clinical Pathways
Clinical Pathways GPS
02/22/2019
Determining how to pay for the treatment of uncommon yet serious diseases is an important consideration in terms of sustainability and patient access. Novel and expensive therapies will create financial pressure for...
Determining how to pay for the treatment of uncommon yet serious diseases is an important consideration in terms of sustainability and patient access. Novel and expensive therapies will create financial pressure for...
...
02/22/2019
Journal of Clinical Pathways
Clinical Pathways GPS
12/13/2018
The Centers for Medicare & Medicaid Services (CMS) released an advanced notice of proposed rulemaking on October 25, 2018, seeking to test  whether using a combination of 3 approaches—an international drug...
The Centers for Medicare & Medicaid Services (CMS) released an advanced notice of proposed rulemaking on October 25, 2018, seeking to test  whether using a combination of 3 approaches—an international drug...
The...
12/13/2018
Journal of Clinical Pathways